Eton Pharmaceuticals, Inc.
ETONNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 22, 2026 close
- Market cap
- $1.64B
- P/E (TTM)
- 129.26
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $14.27$66.37
- Volume (live)
- -
- Avg. volume (3M)
- 545.64K
Eton Pharmaceuticals (ETON) Stock Price & Financial Analysis
Eton Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $48.74 - $50.49 |
|---|---|
| 52-Week High | $66.37 |
| 52-Week Low | $14.27 |
| Open | $49.36 |
| Volume (last close) | 483.68K |
| Average Volume (3M) | 545.64K |
| Revenue (TTM) | 105.59M |
|---|---|
| Net Income (TTM) | 12.69M |
| Free Cash Flow (TTM) | 14.73M |
| EPS (TTM) | $0.41 |
| Profit Margin | 12.02% |
| Operating Margin | 15.44% |
| Return on Equity (ROE) | 27.24% |
| Debt to Equity | 0.60 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.64B |
|---|---|
| Shares Outstanding | 32.79M |
| P/E Ratio (TTM) | 129.26 |
| Price to Sales (P/S) | 15.53 |
| Price to Book (P/B) | 35.20 |
| EV/EBITDA | 80.07 |
| 50-Day MA | $56.44 |
|---|---|
| 200-Day MA | $34.31 |
| 1-Year Change | +169.79% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Eton Pharmaceuticals at a Glance
As of the Oct 22, 2026 close, Eton Pharmaceuticals (ETON) has a market capitalization of $1.64B. The stock trades at 129.3× trailing earnings and 15.5× sales. Over the trailing twelve months it earned $12.69M on revenue of $105.59M (a 12.0% profit margin) and generated $14.73M of free cash flow. Revenue grew 81.5% year over year.
As of its latest reported balance sheet, it holds $26.84M in cash and securities against $27.90M of debt, a net debt position of $1.06M.
Eton Pharmaceuticals does not currently pay a dividend.
The share price is up 169.8% over the past year. At $50.02 (the Oct 22, 2026 close) it sits within its 52-week range of $14.27 to $66.37, above its 200-day moving average of $34.31.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Eton Pharmaceuticals
What is the current stock price for ETON?
As of the Oct 22, 2026 close, ETON stock trades at $50.02. The 52-week range is $14.27–$66.37, with a day range of $48.74–$50.49.
What is the P/E ratio for ETON?
As of the Oct 22, 2026 close, Eton Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 129.3, meaning investors pay $129.3 for every $1 of annual earnings. Eton Pharmaceuticals operates in the Healthcare sector.
Does ETON pay dividends?
Eton Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ETON?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for ETON is Buy.
What is the market cap of ETON?
As of the Oct 22, 2026 close, Eton Pharmaceuticals's market capitalization is $1.64B, classifying it as a small-cap company. Eton Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.